TLX.AX
Telix Pharmaceuticals Ltd
Price:  
24.47 
AUD
Volume:  
4,082,759.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TLX.AX Probability of Bankruptcy

The Probability of Bankruptcy of Telix Pharmaceuticals Ltd (TLX.AX) is -% . This number represents the probability that TLX.AX will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating TLX.AX's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

TLX.AX - ESG ratings

ESG ratings are directly linked to the cost of capital and TLX.AX's ability to raise funding, both of which can significantly affect the probability of Telix Pharmaceuticals Ltd going bankrupt.

ESG Score 59.88
Environment Score 35.58
Social Score 67.64
Governance Score 76.41
Returns
Historical Returns (5 day) -12.73%
Historical Returns (MTD) -9.80%
Historical Returns (YTD) -0.57%
Historical Returns (13 week) -16.00%
Historical Returns (26 week) 14.08%
Historical Returns (52 week) 59.10%
Efficiency
Asset Turnover 0.69
Receiveable Turnover 7.67
Gross Margin 61.79%
Operating Margin 10.49%
Pretax Margin 7.16%
Net Margin 6.37%
Return on Asset (ROA) 4.41
Return on Equity (ROE) 10.27
Return on Investments (ROI) 6.34
Price Metrics
Market Cap (M) 8,267.92
Enterprise Value (M)
52 Week High 31.97
52 Week Low 14.42
Beta 1.45
Average Volume (10 day) 1.75
Average Volume (3 month) 1.60
Price / Earnings (P/E) 181.45
Price / Sales (P/S) 11.56
Earnings
EPS 0.15
Revenue CAGR (5 year) 195.35%
Risk
Current Ratio 2.78
Quick Ratio 2.66